Laboratory of Food, Drugs and Cosmetics (LTMAC), University of Brasilia, 70910-900, Brasília, DF, Brazil.
Natural Products Laboratory, University of Brasilia, 70910-900, Brasília, DF, Brazil.
Colloids Surf B Biointerfaces. 2018 Oct 1;170:341-346. doi: 10.1016/j.colsurfb.2018.06.037. Epub 2018 Jun 19.
In general, colloids provide increased cutaneous permeation of drugs. Still, skin interaction and main pathways for drug diffusion may vary depending on system and formulation characteristics. The knowledge of how different colloidal systems interact with biological membranes and the formulation impact on delivery is especially relevant for drugs that can be encapsulated in multiple nanosystems, as voriconazole (VOR). In here, we compared VOR release and permeation profile from liposomes (LP) and nanostructured lipid carriers (NLC) in aqueous colloidal dispersions and in gel formulations. Despite the controlled drug release provided by gel formulations, formulation only had a significant impact on drug skin accumulation from LP. The reduced mobility in gel formulations compromised follicle deposition and drug retention in the skin. Such a hypothesis was confirmed by permeation experiments evaluating follicle pathway influence. Follicular route also had an influence on delivery from NLC, which was only significant for total drug that reached the acceptor medium. These differences could be attributed to the mechanisms of colloid interaction with the skin and subsequent drug release. Follicle LP deposition and slow drug release leads to higher cutaneous amounts whilst NLC interaction with skin and fast drug release leads to fast drug diffusion and deeper penetration. By the low MIC values encountered against Trichophyton rubrum (∼ 0.001 μg/mL), permeated amounts could inhibit fungal growth, regardless the system. In conclusion, both LP and NLC seem to be valuable systems for cutaneous VOR delivery. Fluidic formulations could provide better efficiency for cutaneous drug delivery from LP.
一般来说,胶体可以增加药物的皮肤渗透。然而,皮肤的相互作用和药物扩散的主要途径可能因系统和制剂的特点而有所不同。了解不同胶体系统如何与生物膜相互作用以及制剂对传递的影响,对于可以封装在多种纳米系统中的药物(如伏立康唑(VOR))尤为重要。在这里,我们比较了脂质体(LP)和纳米结构脂质载体(NLC)在水胶体分散体和凝胶制剂中的 VOR 释放和渗透特性。尽管凝胶制剂提供了控制药物释放,但制剂仅对 LP 中药物的皮肤累积有显著影响。凝胶制剂中药物的流动性降低会损害毛囊的沉积和药物在皮肤中的保留。这种假设通过评估毛囊途径影响的渗透实验得到了证实。毛囊途径对 NLC 的传递也有影响,这仅对到达接受介质的总药物有意义。这些差异可能归因于胶体与皮肤相互作用和随后药物释放的机制。毛囊中 LP 的沉积和缓慢的药物释放导致皮肤中累积的药物量更高,而 NLC 与皮肤的相互作用和快速的药物释放导致药物快速扩散和更深的渗透。由于遇到的低 MIC 值(~0.001μg/mL)对红色毛癣菌(Trichophyton rubrum)有效,渗透量可以抑制真菌生长,无论使用哪种系统。总之,LP 和 NLC 似乎都是用于皮肤 VOR 传递的有价值的系统。流体制剂可以从 LP 提供更好的皮肤药物传递效率。